New York Life Investment Management »

Iovance Biotherapeutics shares owned by New York Life Investment Management

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by New York Life Investment Management from 13F filings

Historical chart of New York Life Investment Management investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by New York Life Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by New York Life Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $463k 57k 8.13
2023-09-30 $265k 58k 4.55
2023-06-30 $475k 68k 7.04
2023-03-31 $435k 71k 6.11

More positions owned by New York Life Investment Management

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Indexiq Etf Tr Candriam Us Larg (IQSU)
Amazon (AMZN)
Indexiq Active Etf Tr Iq Mackay Esg Cr (ESGB)
Indexiq Etf Tr Candriam Us Mid (IQSM)
Indexiq Etf Tr Iq 500 Int Etf (IQIN)
Indexiq Etf Tr Candriam Interna (IQSI)
Meta Platforms Cl A (META)
Ishares Tr Fltg Rate Nt Etf (FLOT)
Indexiq Etf Tr Iq U.s. Small Ca (CSML)
Alphabet Cap Stk Cl A (GOOGL)
Indexiq Etf Tr Iq Cbre Nexgen (ROOF)
Indexiq Etf Tr Ftse Internl Eqt (HFXI)

View all positions for New York Life Investment Management

Top funds holding Iovance Biotherapeutics

Vanguard Group
MHR Fund Management
Perceptive Advisors
venBio Select Advisor
Artisan Partners Limited Partnership
OrbiMed Advisors
Susquehanna International
Balyasny Asset Management
Goldman Sachs Group
Dimensional Fund Advisors
T. Rowe Price Associates
Jpmorgan Chase & Co
Credit Suisse
Long Focus Capital Management
Palo Alto Investors

View all funds holding Iovance Biotherapeutics